4/2
01:13 pm
nvct
Rating for NVCT
Low
Report
Rating for NVCT
4/2
08:31 am
nvct
Nuvectis Pharma, Inc. (NASDAQ: NVCT) is now covered by analysts at Maxim Group. They set a "buy" rating and a $17.00 price target on the stock.
Medium
Report
Nuvectis Pharma, Inc. (NASDAQ: NVCT) is now covered by analysts at Maxim Group. They set a "buy" rating and a $17.00 price target on the stock.
4/2
07:43 am
nvct
Nuvectis Pharma initiated with a Buy at Maxim
Medium
Report
Nuvectis Pharma initiated with a Buy at Maxim
3/17
08:11 am
nvct
Nuvectis Pharma, Inc. (NASDAQ: NVCT) is now covered by analysts at Laidlaw. They set a "buy" rating and a $19.00 price target on the stock.
Medium
Report
Nuvectis Pharma, Inc. (NASDAQ: NVCT) is now covered by analysts at Laidlaw. They set a "buy" rating and a $19.00 price target on the stock.
3/17
08:11 am
nvct
Nuvectis Pharma, Inc. (NASDAQ: NVCT) is now covered by analysts at Laidlaw. They set a "buy" rating and a $19.00 price target on the stock.
Medium
Report
Nuvectis Pharma, Inc. (NASDAQ: NVCT) is now covered by analysts at Laidlaw. They set a "buy" rating and a $19.00 price target on the stock.
3/17
03:28 am
nvct
Nuvectis Pharma initiated with a Buy at Laidlaw
High
Report
Nuvectis Pharma initiated with a Buy at Laidlaw
3/17
03:28 am
nvct
Nuvectis Pharma initiated with a Buy at Laidlaw
High
Report
Nuvectis Pharma initiated with a Buy at Laidlaw